$LITE

Retort Vincent sold $33.0M of LITE

Retort Vincent (SEE REMARKS) sold 38,663 shares of Lumentum Holdings Inc. (LITE) at an average of $852.59 ($842.22–$860.05, $32.96M total) across 18 trades on 2026-08-25 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Retort Vincent
Published Aug 28, 2026, 1:57 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 2:25 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LITE
Bearish
high confidence
Mentioned
$LITE
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LITEBearishMed
01

Why it matters

The disclosed sale represents a material reduction in insider ownership, which can influence market perception.

02

Market read

The insider sale is a primary disclosure that may affect LITE's short‑term price dynamics.

03

What to watch

The 10b5‑1 plan pre‑arranged the sale, reducing the likelihood of insider information driving the transaction.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑08‑25

Background

Form 4 filings disclose insider transactions; large sales by officers are closely watched for signals.

Company-level read

Ticker impact

$LITEBearishHigh confidence
Context

Officer Retort Vincent sold 38,663 shares for $32.96M via a 10b5‑1 plan, reducing his stake to 78,440 shares.

Expected impact

Potential short‑term downside as market digests the large sale.

Evidence & confidence

The sale size ($33M) is material for Lumentum and is disclosed via a primary Form 4 filing, making it actionable for traders.

Market effects

May raise concerns for the photonics and telecom components sector if other insiders follow suit.

Limited to U.S. markets where Lumentum trades.

Low global impact; primarily relevant to investors in Lumentum.

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals; price may remain stable.

Key entities

  • Lumentum Holdings Inc.

    Manufacturer of photonics components, ticker LITE.

  • Retort Vincent

    Company officer who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$COHRMed

Coherent Soars 6%, Lumentum Up 8% as StoneX Starts Both With Buy, Sees 103% Upside

Coherent (COHR) and Lumentum (LITE) shares rose 6% and 8% respectively after StoneX initiated coverage with Buy ratings and price targets of $425 and $1,200. StoneX cites Coherent's six-inch InP laser production and Lumentum's market position in high-speed InP lasers and cloud transceivers. Coherent's earnings estimates have been rising, with fiscal 2027 EPS expected at $9.39. StoneX's target implies a 45x multiple on fiscal 2027 earnings, above Coherent's five-year average of 24x.

$LITEHigh

What Sent Lumentum Stock Higher?

Lumentum (LITE) stock rose 8.2% on October 26, 2026, following a Buy rating and $1,200 price target from StoneX. The gain coincided with a broader rally in optical networking stocks, tied to Anthropic's IPO filing. Lumentum's revenue for fiscal Q4 2026 was $1.01 billion, up 109.3% year-over-year. The stock's movement was part of a larger sector advance, with technology stocks and peers also gaining.

High

Lumentum Stock Jumps 8% on StoneX $1,200 Target

Lumentum's stock rose 8.19% to $818.10 after StoneX initiated coverage with a Buy rating and a $1,200 price target. The company's products are used in AI and data-center infrastructure. Coherent and Applied Optoelectronics also gained. Lumentum's next earnings report is due on 5 November.

$LITEHigh

Hyperliquid’s LITE and AAOI Perpetuals Rose as Open Interest Fell

Hyperliquid perpetual contracts for LITE and AAOI rose 9.53% and 9.91% respectively, while open interest fell. StoneX initiated LITE coverage with a Buy rating and $1,200 target, citing AI-related optoelectronics demand. Open interest for LITE and AAOI dropped 21.97% and 34.61% respectively. Two large accounts closed long positions worth $2.61 million.

$LITEMed

Lumentum stock surges 10% as AI components ‘completely sold out’

Lumentum (LITE) shares rose 8% to $818 after StoneX initiated coverage with a Buy rating and $1,200 target, citing strong demand for AI-related components. Coherent (COHR) and Applied Optoelectronics (AAOI) also gained. Lumentum reported Q4 revenue of $1.01B, up 109.3% YoY, and expects Q1 2027 revenue of $1.225B-$1.275B. Nvidia (NVDA) is a major partner, committing $2B for R&D and manufacturing.

$LITEMed

Lumentum Holdings (LITE) Surges 8% on AI Infrastructure Optimism

Lumentum Holdings (LITE) shares rose 8% to $818.32 on October 26, 2026, driven by optimism about its role in AI infrastructure. StoneX initiated coverage with a Buy rating, citing strong demand for its optical technologies. The company has a P/S ratio of 23.53, significantly above its historical median, and a GF Score of 70, indicating solid financial health and growth but high valuation. Insider selling totaled $175.8 million over the past year, while institutional ownership is mixed.